Company Filing History:
Years Active: 1997-1999
Title: The Innovative Contributions of Francis McCormick
Introduction
Francis McCormick is a notable inventor based in Richmond, CA (US). He has made significant contributions to the field of viral-based therapies, particularly in the treatment of neoplastic conditions. With a total of 5 patents to his name, McCormick's work has the potential to impact cancer treatment significantly.
Latest Patents
One of McCormick's latest patents focuses on cytopathic viruses for therapy and prophylaxis of neoplasia. This patent outlines methods and compositions for treating neoplastic conditions using viral-based therapy. The invention involves administering a mutant virus that lacks viral proteins which bind and/or inactivate p53 or RB to patients with neoplasms that comprise cells lacking p53 and/or RB function. The mutant virus is designed to produce a replication phenotype in neoplastic cells while being unable to replicate in non-neoplastic cells with normal p53 and/or RB function. This selective replication leads to the preferential killing of neoplastic cells, either directly or through the expression of a cytotoxic gene.
Career Highlights
Throughout his career, McCormick has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Onyx Pharmaceuticals, Inc., where he contributed to innovative research and development in cancer therapies. His work has been instrumental in advancing the understanding of viral therapies in oncology.
Collaborations
Due to space constraints, the details of collaborations will be omitted.
Conclusion
Francis McCormick's innovative work in viral-based therapies showcases his commitment to advancing cancer treatment. His patents reflect a deep understanding of the complexities of neoplastic conditions and offer promising avenues for future research and application.